Original Source(s)
Related Content
FDA Cites Manufacturing Issues for Cytisinicline
Application supported by Phase 3 smoking-cessation data and long-term safety findings.
June 22, 2026
-
3 min
Eugene M. & Christine E. Lynn Cancer Institute Treats First Patient with Tarlatamab, Expanding Advanced Therapeutic Options for Patients with Refractory Malignancies
Eugene M. & Christine E. Lynn Cancer Institute has treated its first patient with tarlatamab, marking an important milestone in the expansion of advanced cancer therapies available to patients in Palm Beach County and the surrounding region.
May 7, 2026
-
3 min
Liquid Biopsy Supports Precision Oncology
Experts highlight clinical value, workflow integration, and real-world impact in lung and breast cancer diagnostics
May 22, 2026
-
8 min
